LBA3 Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2- breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial
Saved in:
| Published in | Annals of oncology Vol. 33; p. S164 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Ltd
01.05.2022
|
| Online Access | Get full text |
Cover
Loading…
| Author | Cejalvo Andujar, J.M. Oliveira, M. Margeli Vila, M. Cruz Jurado, J. Martinez Saez, O. Falato, C. Pascual, T. Esker, S. Gonzalez-Farre, B. Espinosa-Bravo, M. Prat, A. Sanfeliu Torres, E. Ciruelos, E.M. Pernas Simon, S. Ferrero Cafiero, J.M. Pare Brunet, L. Fan, P-D. Tolosa, P. Salvador Bofill, F.J. Izarzugaza Peron, Y. |
|---|---|
| Author_xml | – sequence: 1 givenname: A. surname: Prat fullname: Prat, A. organization: Medical Oncology Department, Hospital Clinic de Barcelona/SOLTI/IDIBAPS, Barcelona, Spain – sequence: 2 givenname: C. surname: Falato fullname: Falato, C. organization: SOLTI Cancer Research Group, IDIBAPS - August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain – sequence: 3 givenname: L. surname: Pare Brunet fullname: Pare Brunet, L. organization: SOLTI Cancer Research Group, Data Management, Barcelona, Spain – sequence: 4 givenname: O. surname: Martinez Saez fullname: Martinez Saez, O. organization: SOLTI Cancer Research Group, Medical Oncology Dept., Hospital Clinic of Barcelona, Barcelona, Spain – sequence: 5 givenname: J.M. surname: Cejalvo Andujar fullname: Cejalvo Andujar, J.M. organization: SOLTI Cancer Research Group, Dept. Medical Oncology, Hospital Clinico Universitario de Valencia, Valencia, Spain – sequence: 6 givenname: M. surname: Margeli Vila fullname: Margeli Vila, M. organization: SOLTI Cancer Research Group, Medical Oncology Dept., ICO - Institut Català d'Oncologia Badalona (Hospital Universitario Germans Trias i Pujol), Badalona, Spain – sequence: 7 givenname: P. surname: Tolosa fullname: Tolosa, P. organization: SOLTI Cancer Research Group, Medical Oncology Dept., Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain – sequence: 8 givenname: F.J. surname: Salvador Bofill fullname: Salvador Bofill, F.J. organization: Medical Oncology, Hospital Universitario Virgen de Valme, Seville, Spain – sequence: 9 givenname: J. surname: Cruz Jurado fullname: Cruz Jurado, J. organization: Medical Oncology Department, Hospital Universitario de Canarias, San Cristobal de la Laguna, Spain – sequence: 10 givenname: B. surname: Gonzalez-Farre fullname: Gonzalez-Farre, B. organization: SOLTI Cancer Research Group, Pathology Dept., Hospital Clinic of Barcelona, Barcelona, Spain – sequence: 11 givenname: E. surname: Sanfeliu Torres fullname: Sanfeliu Torres, E. organization: SOLTI Cancer Research Group, Pathology Dept., Hospital Clinic of Barcelona, Barcelona, Spain – sequence: 12 givenname: E.M. surname: Ciruelos fullname: Ciruelos, E.M. organization: SOLTI Cancer Research Group, Medical Oncology Dept., Hospital Universitario 12 de Octubre, Madrid, Spain – sequence: 13 givenname: M. surname: Espinosa-Bravo fullname: Espinosa-Bravo, M. organization: Breast Surgical Unit, Vall d'Hebron University Hospital, Barcelona, Spain – sequence: 14 givenname: Y. surname: Izarzugaza Peron fullname: Izarzugaza Peron, Y. organization: Oncology Department, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain – sequence: 15 givenname: S. surname: Pernas Simon fullname: Pernas Simon, S. organization: SOLTI Cancer Research Group, Medical Oncology Dept., ICO - Institut Català d'Oncologia l'Hospitalet (Hospital Duran i Reynals), L'Hospitalet de Llobregat, Spain – sequence: 16 givenname: S. surname: Esker fullname: Esker, S. organization: Global Medical Department, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA – sequence: 17 givenname: P-D. surname: Fan fullname: Fan, P-D. organization: Global Oncology, Daiichi Sankyo Pharma Development USA, Edison, NJ, USA – sequence: 18 givenname: J.M. surname: Ferrero Cafiero fullname: Ferrero Cafiero, J.M. organization: SOLTI Cancer Research Group, Clinical Research Dept., Barcelona, Spain – sequence: 19 givenname: T. surname: Pascual fullname: Pascual, T. organization: SOLTI Cancer Research Group, Medical Oncology Dept., Hospital Clinic de Barcelona, Barcelona, Spain – sequence: 20 givenname: M. surname: Oliveira fullname: Oliveira, M. organization: SOLTI Cancer Research Group, Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| BookMark | eNp9kM1KAzEUhYMo2FbfwEWWimRMMtOZiQtB608LhYpWcBcyyR1Nmc6UJLX2IXxnU-ra1YV77jmc-_XRYdu1gNAZowmjLL9aJKqNK51wynlC04QX4gD12DAXpKQZO0Q9KnhKimGaHaO-9wtKaS646KGf6d1tip9VcDasl6rCBtz6O4BWLT4fP7yk5P7dXGDbYlCu2RIf1Afg8cvlVRQ5wZUD5QOO5xrcNX60rWqwA79ugsddjcMn4NfZdD7B89mc7ALxxram2-zEbrXqXFi3NmxxLKCaE3RUq8bD6d8coLfHh_loTKazp8nodko0E4UgxnBWsKoyac20qcphroBFSdS1zmsq8kyVxlS8KrJSgK4U0NqA0To3RQkFpAOU7XO167x3UMuVs0vltpJRuUMqF3KPVO6QSprKiDTabvY2iN2-LDjptYX4ubEOdJCms_8H_ALRQIPa |
| CitedBy_id | crossref_primary_10_1177_11795549241260418 crossref_primary_10_1038_s41571_023_00783_w crossref_primary_10_3390_cells12212517 crossref_primary_10_1016_j_ctrv_2022_102436 crossref_primary_10_1016_j_eclinm_2023_102113 crossref_primary_10_1038_s41591_023_02478_2 crossref_primary_10_1177_17588359231183679 crossref_primary_10_1080_14737140_2022_2147510 |
| ContentType | Journal Article |
| Copyright | 2022 European Society for Medical Oncology |
| Copyright_xml | – notice: 2022 European Society for Medical Oncology |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.annonc.2022.03.279 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1569-8041 |
| EndPage | S164 |
| ExternalDocumentID | 10_1016_j_annonc_2022_03_279 S0923753422007578 |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6J9 70D AABJS AABMN AAEDW AAESY AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 0SF AALRI AAYXX ADVLN AEHUL AFETI AFJKZ AFSHK AKRWK CITATION H13 |
| ID | FETCH-LOGICAL-c1979-dd2171bbd3f1cdb856ae1c199ffc6f0964a8ddb2b7489ecbae0fdedcc6d78e7e3 |
| IEDL.DBID | ABVKL |
| ISSN | 0923-7534 |
| IngestDate | Thu Sep 26 18:50:28 EDT 2024 Fri Feb 23 02:39:53 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1979-dd2171bbd3f1cdb856ae1c199ffc6f0964a8ddb2b7489ecbae0fdedcc6d78e7e3 |
| OpenAccessLink | http://www.annalsofoncology.org/article/S0923753422007578/pdf |
| ParticipantIDs | crossref_primary_10_1016_j_annonc_2022_03_279 elsevier_sciencedirect_doi_10_1016_j_annonc_2022_03_279 |
| PublicationCentury | 2000 |
| PublicationDate | May 2022 2022-05-00 |
| PublicationDateYYYYMMDD | 2022-05-01 |
| PublicationDate_xml | – month: 05 year: 2022 text: May 2022 |
| PublicationDecade | 2020 |
| PublicationTitle | Annals of oncology |
| PublicationYear | 2022 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| SSID | ssj0006929 |
| Score | 2.435597 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | S164 |
| Title | LBA3 Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2- breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial |
| URI | https://dx.doi.org/10.1016/j.annonc.2022.03.279 |
| Volume | 33 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fS9xAEF7sCaUvpVZLba3MQx9aZLlkN7fZ-HZa5ayngp7l3sJudleu2LvjmiD9I_o_dyY_REF86GMyTAgzw8w3yew3jH3WkcEmWWdcCx_xxAfDtbEpT0LsgkVIEdVk1WfnanSdfJ8OpmvssDsLQ2OVbe5vcnqdrds7_daa_eVs1r-KEJsg2E4EfW7DwHvB1kWqItFj68ODH6fj-4SsMtFQ7gnJSaE7QVePeZk5ttnEZSgEsZ0Kmul6qkI9qDrHb9jrFi7CsHmjDbbm52_Zy7P2h_gm-zs-GEqoefbL6pex4PyqImJWM4cvo6NLyb9N3VeYzcETkzFHLHjjYXS510eh4GBpJr2Egny_2gfa1nsL2IFXt-VvWARAeAhXF-PJCUwuJpweCHfYxS_uSLhYEnivMCn8gXr7xxa7Pj6aHI54u2GBF3GWZtw57Ehia50MceGsHijjYxRlIRQqYHeTGO2cFZY4anxhjY-C864olEu1T718x3poPv-egUoGRSQTI1MseHHQmUEgKZS02icmVfE2451V82VDpJF3E2Y_88YLOXkhj2SOXthmaWf6_FFA5Jjrn9X88N-aH9krumrmGXdYr1xV_hNijtLutjG1i6j75PQfszbVAQ |
| link.rule.ids | 315,786,790,27602,27957,27958,45698 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbpBtJeStK0JG2TzKGHlCLWlry23NvmhdN4E0icsjchWVLZku4uW5vQH9H_nJEfoYHSQ68eRpiZYeYbe_QNIR9EoLBJFikVzAY0sk5RoXRCIxcapxFSBA1Z9eQyzm6jL9PRdI0c93dh_Fhll_vbnN5k6-7JsLPmcDmbDW8CxCYItiPmP7dh4D0j64gGUjEg6-Ojrxf5Y0KOU9ZS7jFOvUJ_g64Z81JzbLM9lyFjnu2U-Zmuv1WoP6rO2SZ52cFFGLdvtEXW7PwV2Zh0P8S3ye_8aMyh4dmv6h9Kg7Gr2hOzqjkcZqfXnJ5MzUeYzcF6JmOKWPCbhez60xCFjIL2M-kVlN73q8_gt_XeAXbg9V31ExYOEB7CzVVenENxVVB_INxjF7-498LF0oP3GpPCL2i2f7wmt2enxXFGuw0LtAzTJKXGYEcSam24C0ujxShWNkRR6lwZO-xuIiWM0Ux7jhpbamUDZ6wpy9gkwiaWvyEDNJ_dIRBHozLgkeIJFrzQiVQhkGQx18JGKonDXUJ7q8plS6Qh-wmz77L1gvRekAGX6IVdkvSml08CQmKu_6fm2__WPCDPs2KSy_z88uIdeeEl7WzjezKoVrXdQ_xR6f0uvh4A7UjXAQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LBA3+Patritumab+deruxtecan+%28HER3-DXd%29+in+early-stage+HR%2B%2FHER2-+breast+cancer%3A+Final+results+of+the+SOLTI+TOT-HER3+window+of+opportunity+trial&rft.jtitle=Annals+of+oncology&rft.au=Prat%2C+A.&rft.au=Falato%2C+C.&rft.au=Pare+Brunet%2C+L.&rft.au=Martinez+Saez%2C+O.&rft.date=2022-05-01&rft.issn=0923-7534&rft.volume=33&rft.spage=S164&rft_id=info:doi/10.1016%2Fj.annonc.2022.03.279&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_annonc_2022_03_279 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |